Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,023 | -15,701 | -7,239 | -83,440 | -70,135 |
| Depreciation Amortization | 3,173 | 2,103 | 1,049 | 4,254 | 3,179 |
| Accounts receivable | -3,661 | -3,989 | -3,512 | 25 | -6,467 |
| Accounts payable and accrued liabilities | -1,805 | N/A | N/A | N/A | N/A |
| Other Working Capital | 13,775 | -4,174 | -3,568 | 27,246 | -840 |
| Other Operating Activity | 5,803 | 4,384 | 3,857 | 41,921 | 46,679 |
| Operating Cash Flow | $-3,738 | $-17,377 | $-9,413 | $-9,994 | $-27,584 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -247 | -162 | -188 | -146 | -336 |
| PPE Investments | -498 | -394 | -249 | -968 | -681 |
| Other Investing Activity | 70 | 109 | 109 | -5 | -68 |
| Investing Cash Flow | $-675 | $-447 | $-328 | $-1,119 | $-1,085 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 9,542 | 9,542 |
| Debt Repayment | -4,752 | -4,752 | N/A | -10,961 | -10,961 |
| Financing Cash Flow | $-4,752 | $-4,752 | $N/A | $-1,419 | $-1,419 |
| Exchange Rate Effect | -130 | -260 | -103 | 414 | 289 |
| Beginning Cash Position | 51,163 | 51,163 | 51,163 | 63,281 | 63,281 |
| End Cash Position | 41,868 | 28,327 | 41,319 | 51,163 | 33,482 |
| Net Cash Flow | $-9,295 | $-22,836 | $-9,844 | $-12,118 | $-29,799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,738 | -17,377 | -9,413 | -9,994 | -27,584 |
| Capital Expenditure | -498 | -394 | -249 | -971 | -681 |
| Free Cash Flow | -4,236 | -17,771 | -9,662 | -10,965 | -28,265 |